🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
EGFR mutation positive advanced NSCLC patients with CNS metastases were ass...
Status
Unknown
Location
Tangdu Hopspital
Start Date
2022-01-28
Trial ID
NCT06352502
Treatments Being Tested
EGFR mutation positive advanced NSCLC patients with uncleared ctDNA have po...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2022-05-06
Trial ID
NCT05334277
This Study is To Evaluate the Efficacy and Safety of Anlotinib Hydrochlorid...
Status
Completed
Location
cancer hospital Chinese academy of medical sciences
Start Date
2021-01-01
Trial ID
NCT04671303
Treatments Being Tested
This study is a Phase III, international, multicenter, randomized, controll...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-09-26
Trial ID
NCT06970639
This is a multicenter, open-label, phase Ib/II study of YL202 in combinatio...
Status
Recruiting
Location
Anhui Provincial Hospital(The First Affiliated Hospital of Ustc)
Start Date
2025-09-02
Trial ID
NCT07169994
To assess the efficacy and safety of Alflutinib Mesylate versus Gefitinib i...
Status
Active Not Recruiting
Location
cancer hospital Chinese academy of medical sciences
Start Date
2019-05-30
Trial ID
NCT03787992
EGFR-TKI has firmly established itself as a first-line treatment for advanc...
Status
Recruiting
Location
180 Fenglin Road
Start Date
2023-09-19
Trial ID
NCT05987826
Treatments Being Tested
Efficacy and Safety of Sacituzumab Tirumotecan Combined with Furmonertinib ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-02-01
Trial ID
NCT07548060
Treatments Being Tested
This is a Phase Ib clinical study conducted in China to evaluate the treatm...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-02
Trial ID
NCT06868732
Treatments Being Tested
The study is a Phase II study to explore the efficacy and safety of SHR-A21...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2025-11-24
Trial ID
NCT07229729